Biophysics Pharma Inc

Sunovion Pharmaceuticals Inc. is a research-based pharmaceutical company dedicated to treating and preventing human disease through the discovery, development and commercialization of pharmaceutical products directed toward serving unmet medical needs. The company s drug development program has yielded a portfolio of pharmaceutical compounds with a focus on respiratory and central nervous system disorders. Its commercialization efforts are carried out by a United States-based nearly 1,250-person primary care and specialty sales force through co-promotion agreements and through out-licensing partnerships. Sunovion Pharmaceuticals selects development compounds with the potential to offer improvements over existing therapies with respect to efficacy, side-effect profile, dosage forms and, in some cases, the opportunity for additional indications. The focus of its discovery effort is to identify additional drug candidates that are directed toward treating respiratory and central nervous system disorders. These compounds are expected to complement Sunovion Pharmaceuticals pharmaceutical pipeline. Sunovion Pharmaceuticals is headquartered n Marlborough, Mass.

Founded in 2003, Biodel is a pharmaceutical company that develops novel formulations for therapeutic care solutions. It offers medicines for the treatment of various endocrine disorders, including diabetes and osteoporosis. The company uses VIAdel technology, which enables delivery of endocrine therapeutics into blood through various routes of administration. Biodel also offers VIAject, which is an injectable human insulin product. It provides VIAtab, which is an oral human insulin product. The company offers VIAmass and VIAcal that formulates parathyroid hormone and salmon calcitonin for the treatment of osteoporosis. Additionally, Biodel provides a variety of clinical trial services and organizes various community events.

Paratek Pharmaceuticals is a privately held biopharmaceutical company, which is engaged in the discovery and commercialization of new therapeutics that treat life-threatening infectious and other serious diseases. The company s mission at its founding was to overcome the major worldwide problem of bacterial resistance through the application of its proprietary technologies. Paratek was founded in 1996 by Dr. Stuart B. Levy, professor at Tufts University School of Medicine, and by Dr. Walter Gilbert, a Nobel Prize-winning professor emeritus at Harvard University. The company utilizes two scientific platforms to develop multiple products to combat, cure and prevent infectious and other serious diseases. Paratek Pharmaceuticals is headquartered in Boston.